About - Scailyte

WARNING: Beware of Scam Using Our Company Name for Fake Job Interviews

Experts in single-cell science, -omics analytics, and AI.

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex molecular and cellular patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.

Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (scRNA-seq, CITE-seq, CyTOF, TCR-/BCR-seq, etc.) with clinical endpoints, such as disease progression, severity, treatment response and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. Our discoveries elucidate drug MoA and inform on the risk benefit ratio.

The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in CAR-T cell therapies and various clinical projects in Immuno-oncology.

To save lives by enabling precision medicine.

Dr. Peter Nestorov

Founder & Chief Executive Officer

Peter holds a PhD in Genetics from the University of Basel and a degree in Biochemistry from the University of Tübingen. He has been working in the emerging single-cell analysis market since 2015 and this gave him the inspiration to start Scailyte as co-founder and CEO in 2017.

Dr. Corinne Solier

SVP Corporate & Technology Development

Corinne obtained a Masters in Engineering Sciences in Biotechnology and a PhD in Immunology from Université Paul Sabatier in Toulouse, France. She pursued postdoctoral studies at the City of Hope National Medical Center in the U.S.A. in the field of nuclear receptor biochemistry before joining Roche Pharmaceuticals. There, she held various positions in early research and development, intersecting with translational biomarker science, cutting-edge “omics” technologies and innovation. She joined Scailyte in 2021 as Chief Operating Officer.

Book a meeting

Anna Dimitrova, ACCA

Chief Financial Officer

Anna is an ACCA graduate with a Master’s degree in Finance and Banking from Sofia University. Previously, she worked as a finance manager in a fast growing company, auditor in KPMG and business consultant in PwC. Anna joined the Scailyte team in 2018.

Dr. Sarah Carl

Director Data Science

Sarah holds a PhD in Genetics from the University of Cambridge. She worked as a bioinformatician at the Friedrich Miescher Institute in Basel, Switzerland, for four years before joining Scailyte. Sarah joined Scailyte as a data scientist in 2018 and now serves as Director of Data Science.

Diana Stoycheva

Principal Expert Scientist

Diana is a principal scientist with a Masters in Molecular Biotechnology from the University of Heidelberg. She holds a PhD in immunology from HU Berlin and pursued postdoctoral studies in Immunology at the ETH Zurich. Diana’s strong scientific background reflects her personal passion for immunology, immuno-oncology and specifically cell therapies. She joined Scailyte in 2020, evaluating opportunities to apply our AI to new projects in immunology and immuno-oncology.

Book a meeting

Dennis Göhlsdorf

Machine Learning Engineer

Dennis is a multi-disciplinary professional with degrees in both Biochemistry and Computer Science obtained from the University of Tuebingen. He earned his PhD at the Institute of Neuroinformatics at ETH Zurich / University of Zurich. From 2013 until 2016, he worked as a Software Engineer at Google Germany, focusing on Image processing algorithms. He co-founded Scailyte in 2016 and is currently working in the data science team.

Our team

Pascal Koenig

Co-Founder Ava Women & Scailyte Chair of the Board of Directors

Pascal is a co-founder and member of the board of Ava Women, big data and artificial intelligence firm in women’s health with offices in Switzerland and the USA.

Peter Ibbotson

Partner at Swisscom Ventures & Scailyte Board of Directors

Peter Ibbotson is Investor Relations Partner at Swisscom Ventures. He joined Swisscom Ventures in 2017 and is responsible for investor relations and fund administration.

Michael Brenner, MD

Professor of Medicine at Harvard Medical School & Scailyte Advisor to Board of Directors

Prof. Brenner is the director of Brigham and Women’s Hospital’s Human Immunology Center, which creates and performs single-cell transcriptional analysis and functional investigations.

Jan Lichtenberg

Chief Executive Officer InSphero & Scailyte Board of Directors

Jan Lichtenberg is Chief Executive Officer and Co-founder of InSphero, the world-leading biotech specialising in 3D cell-culture technologies for discovery and safety.

Anna Sumeray

Biotech startup CEO, member of the Scailyte Board of Directors

Anna is a global Biotech executive and entrepreneur with broad experience of defining and building successful businesses. Advisor and investor in biotech start-ups, pioneer and general manager of European launch projects and experienced business development leader and negotiator.

Prof. Dr. Manfred Claassen

Founder & Chief Scientific Advisor AI & Single-Cell Analysis

Manfred holds degrees in both Biochemistry and Computer Science from the University of Tübingen and a PhD in the design and validation of proteome measurements from the ETH Zurich.

Prof. Dr. Michael Mueller, MD

Clinical Advisor Endometriosis

Michael is a renowned gynecologist and gynecological oncologist, and managing director of the Women’s Health Clinic at the University Hospital of Bern (Inselspital). Prof. Mueller is supporting Scailyte as a clinical advisor and expert in endometriosis and women’s health.

Prof. Dr. Petter Brodin, MD

Petter is a pioneer in single-cell analysis and, advising Scailyte in immunology and the application of single-cell technologies for clinical research. Prof. Brodin is based at the Karolinska Institute in Sweden and heads a research group that focuses on systems-level analyses of the human immune system. Prof. Brodin is a consultant pediatrician working at the Karolinska University Hospital.

Prof. Dr. Emmanuella Guenova, MD

Clinical Advisor CTCL & Immunology

Emmanuella is a dermatologist, specialist in cutaneous lymphoma and laboratory diagnostics of skin diseases, and appointed professor at the Faculty of Biology and Medicine of the University of Lausanne.

Dr. Michael Stadler

Michael received training in immunology and bioinformatics from the Universities of Lausanne and Geneva. He is a scientific advisor supporting Scailyte’s with the development of our data analytics platform.

Prof. Dr. Tomas Kalina MD

Scientific Advisor Flow Cytometry & Immuno assays

Tomas is a physician and a cytometry expert currently leading a research group focused on disorders of adaptive immunity at the Charles University in Prague. Professor Kalina is supporting Scailyte as a clinical diagnostic advisor with his expertise in cytometry standardization.

Vijay Tiwari

Professor in Genomics at QUB & Scailyte Executive Advisor

Vijay is a Professor in Genomics at QUB, working on achieving an integrated molecular and systems-level understanding of cancer and neurological disorders.

Join the Scailyte team
Are you ready to help us transform biomedical research and healthcare? Please send us your CV, and your letter of motivation to join Scailyte, in an email to: careers@scailyte.com

To achieve our mission, we are looking for smart, passionate and dedicated individuals who share our values by dreaming big, to join our growing, energetic and fun team. We offer flexible working schedules and location.

Recent News

Transforming Healthcare with Unmatched Biomarker Discovery Power

Experience the game-changing convergence of AI and healthcare. Join us on this journey as we transla...

LSX Congress USA 2023

Join Scailyte at the LSX Congress USA in Boston on September 13-14 at the Hynes Convention Centre, B...

Unveiling ScaiVision's Clinical Potential

Embarking on the last leg of our Discovery Potential series, we're delving into ScaiVision's incredi...

ScaiDigest Volume 3: Unveiling Immuno-Oncology's Next Frontier

In Volume 3, our very own Diana Stoycheva takes the helm to explore the fascinating realm of single-...

Revolutionizing Biomarker Discovery: Unlock the Power of Scailyte's AI platform

Dive into the forefront of scientific advancement with Scailyte's groundbreaking AI platform, ScaiVi...

Empowering Precision Healthcare with Unparalleled Discovery Potential

From revealing hidden insights to transforming healthcare, ScaiVision is rewriting the rules of disc...

Accelerating Discoveries with Scailyte's Speed Strength

In the world of clinical research and development, time is of the essence. Our mission at Scailyte i...

Nurturing Wellbeing in Our Workspace: Prioritizing People's Growth

At Scailyte, our commitment to ESG goes beyond numbers. It extends to every individual within our vi...

Recent News

01 /04

Transforming Healthcare with Unmatched Biomarker Discovery Power

Experience the game-changing convergence of AI and healthcare. Join us on this journey as we transla...

LSX Congress USA 2023

Join Scailyte at the LSX Congress USA in Boston on September 13-14 at the Hynes Convention Centre, B...

Recent News

02 /04

Unveiling ScaiVision's Clinical Potential

Embarking on the last leg of our Discovery Potential series, we're delving into ScaiVision's incredi...

ScaiDigest Volume 3: Unveiling Immuno-Oncology's Next Frontier

In Volume 3, our very own Diana Stoycheva takes the helm to explore the fascinating realm of single-...

Recent News

03 /04

Revolutionizing Biomarker Discovery: Unlock the Power of Scailyte's AI platform

Dive into the forefront of scientific advancement with Scailyte's groundbreaking AI platform, ScaiVi...

Empowering Precision Healthcare with Unparalleled Discovery Potential

From revealing hidden insights to transforming healthcare, ScaiVision is rewriting the rules of disc...

Recent News

04 /04

Accelerating Discoveries with Scailyte's Speed Strength

In the world of clinical research and development, time is of the essence. Our mission at Scailyte i...

Nurturing Wellbeing in Our Workspace: Prioritizing People's Growth

At Scailyte, our commitment to ESG goes beyond numbers. It extends to every individual within our vi...

Our vision

We transform single-cell and multi-omics data into actionable biomarkers for your clinical programs

Who We Are

Mission

Our mission is to advance precision medicine with single-cell technologies, artificial intelligence, and multiomics analysis.

Our Values

Vision